Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy

As a multi-target drug to treat ischemic stroke, N-butylphthalide (NBP) is extremely water-insoluble and exhibits limited oral bioavailability, impeding its wide oral application. Effective treatment of ischemic stroke by NBP requires timely and efficient drug exposure, necessitating the development...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ailing Zhang, Jianbo Li, Shuaishuai Wang, Yaru Xu, Qinglian Li, Zhe Wu, Chenxu Wang, Haiyang Meng, Jinjie Zhang
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/90acf7aac0654f6b982a7a7cae89fb53
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:90acf7aac0654f6b982a7a7cae89fb53
record_format dspace
spelling oai:doaj.org-article:90acf7aac0654f6b982a7a7cae89fb532021-11-17T14:21:55ZRapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy1071-75441521-046410.1080/10717544.2021.2000678https://doaj.org/article/90acf7aac0654f6b982a7a7cae89fb532021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/10717544.2021.2000678https://doaj.org/toc/1071-7544https://doaj.org/toc/1521-0464As a multi-target drug to treat ischemic stroke, N-butylphthalide (NBP) is extremely water-insoluble and exhibits limited oral bioavailability, impeding its wide oral application. Effective treatment of ischemic stroke by NBP requires timely and efficient drug exposure, necessitating the development of new oral formulations. Herein, liposomes containing biosurfactant sodium cholate (CA-liposomes) were systemically investigated as an oral NBP delivery platform because of its high biocompatibility and great potential for clinical applications. The optimized liposomes have a uniform hydrodynamic size of 104.30 ± 1.60 nm and excellent encapsulation efficiency (93.91 ± 1.10%). Intriguingly, NBP-loaded CA-liposomes produced rapid drug release and the cumulative release was up to 88.09 ± 4.04% during 12 h while that for NBP group was only 6.79 ± 0.99%. Caco-2 cell monolayer assay demonstrated the superior cell uptake and transport efficiency of NBP-loaded CA-liposomes than free NBP, which was mediated by passive diffusion via transcellular and paracellular routes. After oral administration to rats, NBP-loaded CA-liposomes exhibited rapid and almost complete drug absorption, with a tmax of 0.70 ± 0.14 h and an absolute bioavailability of 92.65% while NBP suspension demonstrated relatively low bioavailability (21.7%). Meanwhile, NBP-loaded CA-liposomes produced 18.30-fold drug concentration in the brain at 5 min compared with NBP suspension, and the brain bioavailability increased by 2.48-fold. As expected, NBP-loaded CA-liposomes demonstrated significant therapeutic efficacy in a middle cerebral artery occlusion rat model. Our study provides new insights for engineering oral formulations of NBP with fast and sufficient drug exposure against ischemic stroke in the clinic.Ailing ZhangJianbo LiShuaishuai WangYaru XuQinglian LiZhe WuChenxu WangHaiyang MengJinjie ZhangTaylor & Francis Grouparticleischemic strokerapid absorptionbrain accumulationdrug releasen-butylphthalideTherapeutics. PharmacologyRM1-950ENDrug Delivery, Vol 28, Iss 1, Pp 2469-2479 (2021)
institution DOAJ
collection DOAJ
language EN
topic ischemic stroke
rapid absorption
brain accumulation
drug release
n-butylphthalide
Therapeutics. Pharmacology
RM1-950
spellingShingle ischemic stroke
rapid absorption
brain accumulation
drug release
n-butylphthalide
Therapeutics. Pharmacology
RM1-950
Ailing Zhang
Jianbo Li
Shuaishuai Wang
Yaru Xu
Qinglian Li
Zhe Wu
Chenxu Wang
Haiyang Meng
Jinjie Zhang
Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
description As a multi-target drug to treat ischemic stroke, N-butylphthalide (NBP) is extremely water-insoluble and exhibits limited oral bioavailability, impeding its wide oral application. Effective treatment of ischemic stroke by NBP requires timely and efficient drug exposure, necessitating the development of new oral formulations. Herein, liposomes containing biosurfactant sodium cholate (CA-liposomes) were systemically investigated as an oral NBP delivery platform because of its high biocompatibility and great potential for clinical applications. The optimized liposomes have a uniform hydrodynamic size of 104.30 ± 1.60 nm and excellent encapsulation efficiency (93.91 ± 1.10%). Intriguingly, NBP-loaded CA-liposomes produced rapid drug release and the cumulative release was up to 88.09 ± 4.04% during 12 h while that for NBP group was only 6.79 ± 0.99%. Caco-2 cell monolayer assay demonstrated the superior cell uptake and transport efficiency of NBP-loaded CA-liposomes than free NBP, which was mediated by passive diffusion via transcellular and paracellular routes. After oral administration to rats, NBP-loaded CA-liposomes exhibited rapid and almost complete drug absorption, with a tmax of 0.70 ± 0.14 h and an absolute bioavailability of 92.65% while NBP suspension demonstrated relatively low bioavailability (21.7%). Meanwhile, NBP-loaded CA-liposomes produced 18.30-fold drug concentration in the brain at 5 min compared with NBP suspension, and the brain bioavailability increased by 2.48-fold. As expected, NBP-loaded CA-liposomes demonstrated significant therapeutic efficacy in a middle cerebral artery occlusion rat model. Our study provides new insights for engineering oral formulations of NBP with fast and sufficient drug exposure against ischemic stroke in the clinic.
format article
author Ailing Zhang
Jianbo Li
Shuaishuai Wang
Yaru Xu
Qinglian Li
Zhe Wu
Chenxu Wang
Haiyang Meng
Jinjie Zhang
author_facet Ailing Zhang
Jianbo Li
Shuaishuai Wang
Yaru Xu
Qinglian Li
Zhe Wu
Chenxu Wang
Haiyang Meng
Jinjie Zhang
author_sort Ailing Zhang
title Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
title_short Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
title_full Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
title_fullStr Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
title_full_unstemmed Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
title_sort rapid and improved oral absorption of n-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/90acf7aac0654f6b982a7a7cae89fb53
work_keys_str_mv AT ailingzhang rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT jianboli rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT shuaishuaiwang rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT yaruxu rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT qinglianli rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT zhewu rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT chenxuwang rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT haiyangmeng rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
AT jinjiezhang rapidandimprovedoralabsorptionofnbutylphthalidebysodiumcholateappendedliposomesforefficientischemicstroketherapy
_version_ 1718425495670882304